Skip to content

QPlus Pediatric Reference Interval

Evaluation of a Pediatric Reference Interval Using QPLUS System

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05645133
Enrollment
93
Registered
2022-12-09
Start date
2023-02-27
Completion date
2023-06-10
Last updated
2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Pediatric ALL

Keywords

QPlus, Quantra, Pediatric, Reference Range

Brief summary

Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.

Detailed description

Single center observational study of the pediatric patient population (\< 18yrs) with normal coagulation function to determine the reference range interval for the clotting parameters reported by the Quantra QPlus system.

Interventions

DEVICEDiagnostic Test

Diagnostic device to monitor coagulation properties of a whole blood sample at the point of care

Sponsors

HemoSonics LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* \<18yrs * Scheduled for procedure requiring anesthesia * Access to blood sampling * Consented

Exclusion criteria

* \>18yrs of age * pre-term babies * patients with know hematological disorders * Difficult to obtain blood sampling * Has received a blood product transfusion within the last 24hrs. * Legal guardian unwilling to consent

Design outcomes

Primary

MeasureTime frameDescription
Reference range interval for measurement of clot time (CT) parameterBaseline, after access placement before any proceduresReference range interval determined in this study will serve as the reference for CT results in this particular population
Reference range interval for measurement of clot time (CTH) parameterBaseline, after access placement before any proceduresReference range interval determined in this study will serve as the reference for CTH results in this particular population
Reference range interval for measurement of clot stiffness (CS) parameterBaseline, after access placement before any proceduresReference range interval determined in this study will serve as the reference for CS results in this particular population
Reference range interval for measurement of Fibrinogen Contribution to clot stiffness (FCS) parameterBaseline, after access placement before any proceduresReference range interval determined in this study will serve as the reference for FCS results in this particular population
Reference range interval for measurement of Platelet Contribution to clot stiffness (PCS) parameterBaseline, after access placement before any proceduresReference range interval determined in this study will serve as the reference for PCS results in this particular population

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026